Neuroone Medical Technologies (NMTC) Current Assets (2010 - 2026)

Neuroone Medical Technologies has disclosed Current Assets across 17 years of filings, most recently posting $7.1 million for Q1 2026.

• Quarterly Current Assets rose 89.33% year-over-year to $7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.1 million (up 89.33% YoY) and the FY2025 annual result came in at $10.2 million, up 120.83% from the prior year.
• Current Assets fell to $7.1 million in Q1 2026, from $8.1 million in the prior quarter.
• Across five years, Current Assets topped out at $13.4 million in Q1 2022 and bottomed at $3.8 million in Q1 2025.
• The 5-year median for Current Assets is $7.1 million (2026), against an average of $7.5 million.
• Year-over-year, Current Assets slumped 55.36% in 2023 and jumped 148.95% in 2025.
• Neuroone Medical Technologies' Current Assets stood at $9.0 million in 2022, then slumped by 43.2% to $5.1 million in 2023, then increased by 12.15% to $5.7 million in 2024, then soared by 41.24% to $8.1 million in 2025, then declined by 11.9% to $7.1 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $7.1 million, $8.1 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.